Safety and Efficacy of Campath in Nonmyeloablative Transplantation
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Objective of the low-dose transplant regimen must produce the following effects:
1. Suppression of the patient's immune system to prevent rejection of the donor cells;
2. Control of the lymphoma. The pretransplant regimen must suppress the lymphoma
sufficiently to prevent marked progression of the tumor and allow time for the GVT
effect to occur.